STOCK TITAN

LiveRamp completes merger at $38.50 per share

RAMP trading was halted before the November 2, 2026 market open, and the NYSE filed to delist the common stock.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

LiveRamp Holdings, Inc. completed its merger with MMS USA Holdings, Inc. on November 2, 2026, with LiveRamp surviving as the parent’s wholly owned direct subsidiary. At the effective time, each outstanding common share—except shares held by appraisal-rights holders, the company, the parent, the merger subsidiary, and specified wholly owned subsidiaries—converted into a right to receive $38.50 in cash per share, without interest.

LiveRamp shares were halted and removed from NYSE trading before the market opened on November 2; the NYSE filed Form 25 to delist the stock. LiveRamp intends to file Form 15 to suspend its Exchange Act reporting obligations. Its pre-merger directors resigned and executive officers ceased serving; the merger subsidiary’s officers and directors became the surviving corporation’s officers and directors. Matt Karasick, the company’s Chief Product Officer and a named executive officer, has a total retention amount of $1,625,000, payable on the 30th day after the effective time or earlier if the parent determines, contingent on signing a mutually agreeable employment agreement by November 30, 2026.

Insights

Analyzing...

Item 2.01 Completion of Acquisition or Disposition of Assets Financial
The company completed a significant acquisition or sale of business assets.
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Securities
The company received a delisting notice, failed to satisfy a continued-listing rule or standard, or transferred its listing.
Item 3.03 Material Modification to Rights of Security Holders Securities
A change was made that materially affects the rights of existing shareholders (e.g., dividend rights, voting rights).
Item 5.01 Changes in Control of Registrant Governance
A change in control of the company occurred, such as through a merger, takeover, or management buyout.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Governance
The company amended its charter documents, bylaws, or changed its fiscal year.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Merger consideration $38.50 per share Cash payable without interest for each outstanding share converted at the effective time, subject to specified exclusions
Total retention amount $1,625,000 Matt Karasick; contingent on signing a mutually agreeable employment agreement
Retention payment timing 30th day following the effective time Parent may determine an earlier payment date
Employment agreement deadline November 30, 2026 Deadline for signing the mutually agreeable employment agreement tied to the retention amount
Merger Consideration financial
"right to receive $38.50 in cash, without interest (the “Merger Consideration”)"
Merger consideration is the total payment a company or buyer offers to shareholders of a target company in exchange for combining the two businesses, and can include cash, shares in the surviving company, debt assumption, or a mix of these. Investors care because the form and amount affect the deal’s value, tax consequences, immediate cash received versus future ownership, and the risk and upside of holding new shares — similar to choosing between cash now or stock that could grow later.
rights of appraisal regulatory
"properly perfected their rights of appraisal within the meaning of Section 262"
Form 25 regulatory
"Notification of Removal From Listing and/or Registration on Form 25"
A Form 25 is an official filing with the U.S. Securities and Exchange Commission used to remove a company's stock or other security from a national exchange list. Investors should care because delisting often means less visibility, lower trading volume and wider price swings—similar to a product moving from a major supermarket to a small local market, which can make buying, selling and valuing the security more difficult.
Form 15 regulatory
"certification on Form 15 to cause the Company’s reporting obligations"
A Form 15 is a short filing a public company uses with the U.S. Securities and Exchange Commission to stop or pause its routine public reporting requirements when it meets certain legal thresholds (such as a low number of public shareholders) or other qualifying conditions. Investors should care because filing one typically means less public financial information and lower trading liquidity—similar to a shop taking down its public notice board, making it harder to track performance and buy or sell shares.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What cash consideration does the LiveRamp (RAMP) merger provide per share?

Each outstanding LiveRamp common share, except specified excluded shares, converted into a right to receive $38.50 in cash per share, without interest.

What happened to LiveRamp (RAMP) stock after the merger?

Trading in LiveRamp common stock was halted and the shares were removed from NYSE trading before the market opened on November 2, 2026. The NYSE filed Form 25 to delist the stock, and LiveRamp intends to file Form 15 to suspend its Exchange Act reporting obligations.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false --03-31 0000733269 0000733269 2026-11-02 2026-11-02 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 2, 2026

 

LIVERAMP HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware 001-38669 83-1269307

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

 

225 Bush Street, Seventeenth Floor

San Francisco, CA 94104

(Address of principal executive offices, including zip code)

 

(888) 987-6764

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240-14d-2(b))

 

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol   Name of each exchange on which registered
Common Stock, $0.10 par value   RAMP   New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨ 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

 

 

 

 

 

 

INTRODUCTORY NOTE

 

On November 2, 2026 (the “Closing Date”), MMS USA Holdings, Inc., a Delaware corporation (“Parent”), completed the previously announced acquisition of LiveRamp Holdings, Inc., a Delaware corporation (the “Company”), pursuant to the Agreement and Plan of Merger, dated as of May 16, 2026 (the “Merger Agreement”), by and among Parent, Covey Merger Sub, Inc., a Delaware corporation and a wholly owned direct subsidiary of Parent (“Merger Sub”), the Company, and solely for the purposes of Section 10.14 thereof, Publicis Groupe S.A., a French société anonyme. Pursuant to the terms of the Merger Agreement, on the Closing Date, Merger Sub merged with and into the Company (the “Merger”), with the Company surviving as a wholly owned direct subsidiary of Parent (the “Surviving Corporation”).

 

The Merger Agreement and the transactions contemplated thereby, including the Merger, were previously described in the Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) by the Company on May 18, 2026 and the definitive proxy statement filed with the SEC by the Company on July 6, 2026.

  

Item 2.01 Completion of Acquisition or Disposition of Assets.

 

The information set forth in the Introductory Note of this Current Report on Form 8-K is incorporated by reference into this Item 2.01.

 

Pursuant to the Merger Agreement, at the effective time of the Merger (the “Effective Time”), each share of common stock, par value $0.10 per share, of the Company (“Company Common Stock”) issued and outstanding immediately prior to the Effective Time (other than any (i) Company Common Stock owned by stockholders that properly perfected their rights of appraisal within the meaning of Section 262 of the Delaware General Corporation Law, (ii) Company Common Stock owned by the Company, Parent or Merger Sub and (iii) Company Common Stock owned by any direct or indirect wholly owned subsidiary of Parent (other than Merger Sub) or of the Company) was converted into the right to receive $38.50 in cash, without interest (the “Merger Consideration”).

 

In addition, pursuant to the Merger Agreement, at the Effective Time:

 

·Options: Each outstanding option to purchase shares of Company Common Stock (each, a “Company Option”) was converted into a restricted cash award in an amount equal to (i) the excess of the Merger Consideration over the applicable exercise price per share of such Company Common Stock multiplied by (ii) the number of shares of Company Common Stock subject to such Company Option immediately prior to the Effective Time. The restricted cash award is otherwise subject to the same terms and conditions as applicable to such Company Option as of immediately prior to the Effective Time but will vest in full following certain qualifying terminations of employment that occur within 24 months following the Effective Time in accordance with the terms of the Merger Agreement.

 

·Restricted Stock Awards: Each outstanding award of restricted shares of Company Common Stock (each a “Company Restricted Stock Award”) was converted into a restricted cash award in an amount equal to (i) the number of shares of Company Common Stock subject to such Company Restricted Stock Award immediately prior to the Effective Time multiplied by (ii) the Merger Consideration. The restricted cash award is otherwise subject to the same terms and conditions as applicable to such Company Restricted Stock Award as of immediately prior to the Effective Time but will vest in full following certain qualifying terminations of employment that occur within 24 months following the Effective Time in accordance with the terms of the Merger Agreement.

 

 

 

 

·Company Restricted Stock Unit Awards and Performance Stock Unit Awards: Each outstanding time-vesting restricted stock unit award (each, a “Company RSU Award”) and each outstanding performance-vesting restricted stock unit award (each, a “Company PSU Award”) was converted into a restricted cash award in an amount equal to (i) the number of shares of Company Common Stock subject to such Company RSU Award or Company PSU Award (determined based on (x) in the case of Company PSU Awards granted on or prior to December 31, 2025 that were subject to “Rule of 40” performance conditions, 128% of the target level of performance (in the case of fiscal year 2025 grants) and 139% of the target level of performance (in the case of fiscal year 2026 grants) for both completed and incomplete performance periods, (y) in the case of all other Company PSU Awards granted on or prior to December 31, 2025, actual performance for completed performance periods and the greater of the target level and the actual level of performance through the Effective Time for incomplete performance periods and (z) in the case of Company PSU Awards granted after December 31, 2025, target level of performance) immediately prior to the Effective Time, multiplied by (ii) the Merger Consideration. The restricted cash award is otherwise subject to the same terms and conditions as applicable to such Company RSU Award or Company PSU Award, as applicable, as of immediately prior to the Effective Time, except that the performance-based vesting conditions applicable to Company PSU Awards ceased to apply, and the awards will vest in full following certain qualifying terminations of employment that occur within 24 months following the Effective Time in accordance with the terms of the Merger Agreement.

 

The foregoing summary does not purport to be complete and is qualified in its entirety by reference to the full text of the Merger Agreement, which is attached hereto as Exhibit 2.1 and is incorporated herein by reference.

 

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

 

The information set forth in the Introductory Note and Item 2.01 of this Current Report on Form 8-K is incorporated by reference into this Item 3.01.

 

On the Closing Date, the Company notified the New York Stock Exchange (the “NYSE”) of the completion of the Merger and requested that the trading of shares of Company Common Stock on the NYSE be halted prior to the market open on November 2, 2026. As a result, all shares of Company Common Stock were removed from trading on the NYSE prior to the market open on November 2, 2026. The NYSE has filed with the SEC a Notification of Removal From Listing and/or Registration on Form 25 in order to delist the Company Common Stock from the NYSE. Such delisting will result in the deregistration of the Company Common Stock under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The Company intends to file with the SEC a certification on Form 15 to cause the Company’s reporting obligations under Sections 13 and 15(d) of the Exchange Act to be suspended.

 

Item 3.03 Material Modification to Rights of Security Holders.

 

The information set forth in the Introductory Note and Items 2.01, 3.01 and 5.03 of this Current Report on Form 8-K is incorporated by reference into this Item 3.03.

 

As a result of the Merger, each share of Company Common Stock that was issued and outstanding immediately prior to the Effective Time (except as described in Item 2.01 of this Current Report on Form 8-K) was cancelled and converted automatically, at the Effective Time, into the right to receive the Merger Consideration. Accordingly, at the Effective Time, the holders of such Company Common Stock ceased to have any rights as stockholders of the Company, other than the right to receive the Merger Consideration.

 

Item 5.01 Change in Control of Registrant.

 

The information set forth in the Introductory Note and Items 2.01, 3.01, 3.03 and 5.03 of this Current Report on Form 8-K is incorporated by reference into this Item 5.01.

 

As a result of the Merger, at the Effective Time, a change in control of the Company occurred and the Company became a wholly owned direct subsidiary of Parent.

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

The information set forth in the Introductory Note and Item 2.01 of this Current Report on Form 8-K is incorporated by reference into this Item 5.02.

 

Director and Officer Changes

 

In connection with the Merger, each member of the board of directors of the Company as of immediately prior to the Effective Time resigned as a director of the Company, effective as of the Effective Time. These resignations were in connection with the Merger and not a result of any disagreements between the Company and the resigning directors on any matter relating to the Company’s operations, policies or practices. In addition, each executive officer of the Company as of immediately prior to the Effective Time ceased to serve as an executive officer of the Company, effective as of the Effective Time. In accordance with the Merger Agreement, from and after the Effective Time, the officers and directors of Merger Sub immediately prior to the Effective Time became the officers and directors of the Surviving Corporation.

 

In accordance with the terms of the Merger Agreement, the Company approved the grant of an additional retention award to Matt Karasick, the Company’s Chief Product Officer and a named executive officer, for a total retention amount of $1,625,000, which is inclusive of the cash retention award that was previously approved and disclosed for Mr. Karasick in the definitive proxy statement filed by the Company in respect of the Merger on July 6, 2026. The award is payable on the thirtieth day following the Effective Time (or such earlier date as Parent may determine), contingent upon Mr. Karasick signing a mutually agreeable employment agreement on or before November 30, 2026.

 

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

 

The information set forth in the Introductory Note and Item 2.01 of this Current Report on Form 8-K is incorporated by reference into this Item 5.03.

 

Pursuant to the Merger Agreement, at the Effective Time, the Company’s certificate of incorporation was amended and restated in its entirety and as so amended and restated became the certificate of incorporation of the Surviving Corporation, and the bylaws of the Company were amended and restated in their entirety and as so amended and restated became the bylaws of the Surviving Corporation. Copies of the amended and restated certificate of incorporation and the bylaws of the Surviving Corporation are filed as Exhibit 3.1 and Exhibit 3.2, respectively, to this Current Report on Form 8-K and are incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) The following items are filed as exhibits to this Current Report on Form 8-K.

 

Exhibit
Number
  Description of Exhibit
     
2.1*+   Agreement and Plan of Merger, dated as of May 16, 2026, by and among MMS USA Holdings, Inc., Covey Merger Sub, Inc., LiveRamp Holdings, Inc. and solely for purposes of Section 10.14 thereto, Publicis Groupe S.A. (incorporated herein by reference to Exhibit 2.1 to LiveRamp Holdings, Inc.’s Current Report on Form 8-K filed with the SEC on May 18, 2026)
3.1   Fourth Amended and Restated Certificate of Incorporation of LiveRamp Holdings, Inc.
3.2   Fourth Amended and Restated Bylaws of LiveRamp Holdings, Inc.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

* Previously filed.
+

Schedules and similar attachments have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company agrees to furnish supplementally a copy of any omitted schedule or similar attachment to the SEC upon request; provided, however, that the Company may request confidential treatment pursuant to Rule 24b-2 of the Exchange Act, for any schedules so furnished.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  LIVERAMP HOLDINGS, INC.
   
  By: /s/ Jerry Jones
    Name: Jerry Jones
    Title: EVP, Legal & Data Ethics
   
Date: November 2, 2026  

  

 

 

 

 

 

Filing Exhibits & Attachments

5 documents

Keep reading